Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Molecular imaging in Libman-Sacks endocarditis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mycobacterium bovis meningitis in young Nigerian-born male

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999-2011

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Postoperative complications as a predictor for survival after liver transplantation - proposition of a prognostic score

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Data on occurrence and risk factors for pneumocystis pneumonia (PCP) in patients with end-stage renal disease (ESRD) are sparse. Methods: This was a nationwide population-based study assessing occurrence and risk factors for PCP among patients with ESRD and population controls over a 21-year period (1/1 1990 to 31/12 2010). Using Danish registry data, first-time diagnoses of PCP were identified. Results: We identified 13 296 adult patients with ESRD and 244 255 controls, yielding 63 560 and 2 223 660 person-years of follow-up (PYFU), respectively. Fifty-eight first-time diagnoses of PCP were recorded in the ESRD group. Forty-six episodes occurred among renal transplant recipients (RTx) and 12 among haemodialysis patients (HD), yielding incidence rates of 181 (136-242) and 43.1 (24.5-75.9) per 100 000 PYFU. Compared to population controls, we found incidence rate-ratios of 125.9 (78.4-204) among RTx and 29.9 (14.1-59.7) among HD patients. Risk factors for PCP in RTx were age 50-65 years, age > 65 years, diabetes, polycystic kidney disease and hypertensive kidney disease/nephrosclerosis with an IRR of 2.22 (1.14-4.31), 3.12 (1.35-7.21), 3.44 (1.16-10.2), 4.25 (1.55-11.7) and 3.87 (1.49-10.0), respectively, and more than 36 months of dialysis before transplantation with an IRR of 1.99 (1.03-3.84). Among RTx the risk of PCP was highest during the first 6 months post-transplantation and increased from the beginning (IR1990-94 = 111 (46.3-267) per 100 000 PYFU) towards the end of the study period (IR2005-10 = 299 (203-439)). Conclusion: The PCP risk is substantial in RTx within the first 6 months of transplantation, emphasizing the potential benefit of prophylactic treatment in the early post-transplant period. Importantly, we identified subgroups within the RTx group that require more attention.

Original languageEnglish
JournalScandinavian Journal of Infectious Diseases
Volume46
Issue number10
Pages (from-to)704-11
ISSN0036-5548
DOIs
Publication statusPublished - 18 Aug 2014

ID: 44528045